Federal Circuit Affirms All Holdings In Glaucoma Drug Patent Dispute
WASHINGTON, D.C. — A Texas federal judge did not err in holding various claims of several patents covering the glaucoma drug Lumigan not invalid as obvious or for lack of enablement...To view the full article, register now.
Already a subscriber? Click here to view full article